These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33005991)
21. ASO Author Reflections: The Peritoneum is an Active Immunological Compartment. Thorgersen EB; Flatmark K Ann Surg Oncol; 2021 Sep; 28(9):5263-5264. PubMed ID: 33939046 [No Abstract] [Full Text] [Related]
22. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391 [TBL] [Abstract][Full Text] [Related]
23. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases. Sluiter NR; Tuynman JB Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638 [No Abstract] [Full Text] [Related]
24. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167 [TBL] [Abstract][Full Text] [Related]
25. ASO Author Reflections: The Prognostic Value of Time to Metastasis in Colorectal Liver Metastasis. Höppener DJ; Verhoef C Ann Surg Oncol; 2019 Dec; 26(Suppl 3):798-799. PubMed ID: 31646452 [No Abstract] [Full Text] [Related]
26. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318 [TBL] [Abstract][Full Text] [Related]
27. ASO Author Reflections: Potential Values of Peritoneal Cell-Free Tumor DNA Testing. Chan CHF Ann Surg Oncol; 2020 Dec; 27(13):5072-5073. PubMed ID: 33078317 [No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies. Moaven O; Miller LD; Levine EA Ann Surg Oncol; 2020 Dec; 27(13):5024-5025. PubMed ID: 32749622 [No Abstract] [Full Text] [Related]
30. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer. Jeon Y; Park EJ; Lim JH; Baik SH World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188 [TBL] [Abstract][Full Text] [Related]
31. ASO Author Reflections: Recurrence Predictors in Mucinous Appendiceal Tumors. Baumgartner JM Ann Surg Oncol; 2018 Dec; 25(Suppl 3):763-764. PubMed ID: 30411269 [No Abstract] [Full Text] [Related]
32. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study. Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847 [TBL] [Abstract][Full Text] [Related]
33. ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters. Choi AH; Senthil M Ann Surg Oncol; 2020 Dec; 27(13):4949. PubMed ID: 32627117 [No Abstract] [Full Text] [Related]
34. [Management of synchronous distant metastasis of colorectal cancer]. Murono K; Ishihara S; Watanabe T Nihon Shokakibyo Gakkai Zasshi; 2017; 114(7):1209-1216. PubMed ID: 28679978 [No Abstract] [Full Text] [Related]